Luteolin inhibits the mitogen-activated protein kinase (MAPK) signaling pathway of the downstream signaling pathway of epidermal growth factor, thereby inhibiting the proliferation of glioblastoma (Anson et al., 2018). Here, EGF is linked to glioblastoma.